Ford readies to revamp Lincoln yet again to save brand

1 / 2
2 / 2
Updated 07 December 2012
Follow

Ford readies to revamp Lincoln yet again to save brand

DETROIT: After failing numerous times to revamp its lagging Lincoln brand, Ford Motor Co. is preparing to try yet again with a new compact crossover aimed at younger drivers looking for a finely crafted but low-key luxury car.
The Lincoln MKC, will be previewed as a concept at the Detroit auto show in January and should reach US dealers in early 2014, according to people familiar with the matter.
The MKC is the second of four core models that Lincoln will pitch to an growing market insiders call “discreet luxury,” epitomized by fashion labels such as Paul Smith and Bottega Veneta that avoid overt symbols of wealth.
But auto experts say Ford will find it difficult to overhaul and reposition an ageing brand broadly viewed as musty. It also faces competition in the luxury compact market from BMW AG’s, Honda Motor Co’s Acura RDX and others.
“What they always forget about is that brands carry baggage,” said John Wolkonowicz, an independent auto analyst and historian. “You can’t just push a magic button and the baggage is gone, and suddenly Lincoln can be anything I want it to be.”
Ford says this overhaul will be different because it has pruned its brands since 2006. Selling Volvo, Jaguar/Land Rover and Aston Martin leaves ample resources to focus on Lincoln and distinguish it from Ford, company executives have said.
Lincoln, which Ford purchased 90 years ago, was the top-selling US luxury car in 1998, but has since tumbled into eighth place. Its sales have declined from a peak of more than
231,000 in 1990 to just under 75,000 in 2012. Daimler AG’s Mercedes-Benz, the top-selling luxury brand, has sold about three times more vehicles than Lincoln this year.
The average Lincoln buyer is 65 years old. Ford wants to lower that to 57 and raise the target average income by more than 50 percent to nearly $ 160,000 a year.
The redesigned 2013 MKZ midsize sedan, which arrives at dealers later this month, is the first of the new Lincoln lineup. Before it left the studio, the MKZ was reworked by
40-year-old chief designer Max Wolff, who was lured to Lincoln from Cadillac in January 2011.
The MKC crossover will be the first Lincoln model completely designed by Wolff, whose projects at rival General Motors Co. included the popular 2013 Cadillac XTS.
Under Wolff, designers are crafting a new look aimed at younger consumers “who enjoy fine things, but are not overt ‘badge-wearers,’” said a Ford executive familiar with Lincoln’s evolving game plan.
Wolff is also overseeing the styling of two other Lincolns — the redesigned 2015 MKX midsize crossover, due in the autumn of 2014, and the redesigned 2016 MKS full size sedan, expected in the spring of 2015, according to two industry analysts familiar with the plans.
“What’s good is Lincoln’s push to differentiate itself from Ford,” said Sam Stevens, a dealer for Stevens Auto Group in Milford, Connecticut. “Why would you buy (Lincoln) if you can buy the same thing on the floor for less?”
Ford declined to confirm its $ 1 billion investment in the Lincoln brand or its planned compact crossover.
The No. 2 US automaker renamed the brand the Lincoln Motor Co. recently and announced a Super Bowl spot to show off its new vision.
Lincoln is also considering — but has not approved for production — several products in addition to the four core models, said the analysts familiar with Ford’s line-up.
For 2016, a luxury rear-wheel-drive coupe could share its underpinnings with the Ford Mustang and could be assembled at Ford’s Flat Rock plant in Michigan.

Ford says its new Lincoln lineup could draw about a quarter of the US premium car market now up for grabs as the economy recovers.
“They are looking for something new,” said Jim Farley, head of global marketing and the Lincoln brand, in an interview with Reuters Television. “They really don’t have a brand
out there that really talks to them individually.”
But Wolkonowicz and other experts said the Lincoln lineup still does not have a “design signature” such as the sharp, more aggressive look Wolff helped refine at Cadillac.
“Lincoln’s image is lagging behind, compared to its actual product line,” said TrueCar.com analyst Jesse Toprak. “The product is the best they’ve had, but people make decisions based on the image of the brand.”
Although they are being extensively redesigned, the 2015 MKX and the 2015 MKS will share the same midsize platform with the 2013 MKZ and its sibling, the 2013 Ford Fusion, according to the analysts familiar with Lincoln’s plans.
The new MKC will share its basic underpinnings with the Ford Escape, which is built on a version of the company’s global compact platform.
In addition to those four core products, Lincoln plans to introduce a mildly revised version of its big Navigator utility vehicle in the autumn of 2013, said a company executive familiar with the brand’s launch schedule.
The 2014 Navigator is expected to use Ford’s powerful EcoBoost V6 engine instead of the current 5.4-liter V8, but will retain its truck-based body-on-frame architecture and ample size. Another carryover model is the MKT full size crossover, which received a modest update earlier this year, but is not slated for any major changes over the next three years, according to the analysts.
Lincoln is considering a near-luxury compact sedan which, like the MKC crossover, would be based on the global compact platform, for 2016 or later.
If approved, the small sedan likely would be sold in the US and China, where the brand is being launched in 2014, said a company executive familiar with Lincoln’s plans.


AI’s shift toward proactive healthcare

Updated 11 sec ago
Follow

AI’s shift toward proactive healthcare

  • Experts reveal how AI is reducing burnout and streamlining workflows

JEDDAH: Artificial intelligence is increasingly moving from the margins of healthcare innovation into its operational core. Rather than replacing clinicians, AI is being deployed to address persistent challenges across health systems, from administrative overload and staff burnout to fragmented data and inefficient patient flow.

Speaking to Arab News, Abbes Seqqat, chief executive officer of Rain Stella Technologies, and Eric Turkington, chief product officer, discussed how AI is already transforming healthcare delivery — and why its impact is most meaningful when embedded directly into clinical workflows rather than treated as a standalone tool.

Seqqat describes AI’s role as accelerating a structural shift in healthcare delivery. “AI is accelerating the shift in healthcare from reactive to proactive care, because AI fundamentally helps detect, analyze and predict,” he said, noting that many health systems lack the resources to perform these tasks at scale.

Abbes Seqqat, chief executive officer of Rain Stella Technologies. (RST photo)

While AI use cases in healthcare are broad, Seqqat emphasized that the most effective applications today focus on operational and clinical fundamentals, including reducing administrative burden, identifying patient risks earlier, and capturing clinical data more reliably and in real time.

RST’s portfolio reflects this approach, spanning surgical data capture and workflow automation, cloud-based electronic medical records, and health information exchange. Across these systems, the common goal is improving data quality and usability so clinicians can spend less time managing information and more time delivering care.

According to Turkington, RST’s systems rely on a mix of established and emerging AI technologies.

RST's Equinox offers a streamlined workflow, minimizing redundant data entry, and also allows for seamless integration with other systems. (RST images)

“Across the portfolio, we are using a wide range of AI and predictive technologies, from voice technology to reliably capture clinician inputs, to large language models that analyze and act on collected data,” he said.

A key focus has been adapting AI to regional and clinical realities. Voice models, for example, have been trained on UAE and GCC accents and grounded in medical terminology to improve accuracy in real-world settings. RST also uses retrieval-augmented generation and multi-agent AI architectures, allowing different AI components to perform specialized tasks such as classifying surgical notes, identifying unusual events, or assisting with billing and coding, Turkington explained.

DID YOU KNOW?

• AI can detect, analyze, and predict patient risks faster than traditional methods.

• Systems like Equinox use voice input and predictive analytics to actively support clinical decisions.

• AI assistants provide real-time updates, automate documentation, and improve coordination in operating theaters.

One of the central concerns around AI adoption is whether it adds complexity to already demanding clinical roles. Seqqat argues the opposite should be the goal.
“For nurses and frontline staff, AI’s greatest contribution is removing the invisible administrative friction that leads to burnout,” Seqqat said.

In operating theaters, AI systems can replace manual coordination methods such as phone calls and whiteboards by providing real-time situational awareness. By automating updates, anticipating delays, and serving as an on-demand clinical notepad, AI reduces cognitive load and allows staff to remain focused on patient care, he explained.

RST’s voice-enabled assistant, Orva, is designed specifically for perioperative environments.

Orva captures live updates through voice input, enabling it to surface delays, flag bottlenecks, and prompt coordination between departments. (RST photo)

Turkington said it enables hands-free documentation and coordination, helping surgical teams manage schedules and resources more effectively.

By capturing live updates through voice input, Orva can surface delays, flag bottlenecks, and prompt coordination between departments. It also assists with documentation and coding, reducing errors and supporting more accurate reimbursement— an area where incomplete records often create downstream challenges.

Electronic medical records remain central to healthcare delivery, but Turkington noted that AI can move them beyond passive data repositories.

Eric Turkington, chief product officer of Rain Stella Technologies. (RST photo)

“We designed Equinox as an EMR that enables you to spend less time with the software and more time with patients,” Turkington said.

Through voice input, automated documentation from visual annotations, and AI-generated pre-visit summaries, the system can actively support clinicians rather than slow them down. Predictive analytics, such as identifying no-show risks or highlighting care gaps, further shift EMRs toward decision-support tools rather than administrative obligations.

Both executives stressed that AI’s effectiveness depends heavily on data access and quality. Seqqat pointed to interoperability as a prerequisite rather than an afterthought.
“AI is only as powerful as the data it can access,” he said, adding that fragmented records limit both clinical insight and system-wide learning.

Health information exchanges, such as RST’s Constellation platform, enable patient data to be viewed longitudinally across providers. AI can then assist with patient identity matching and population-level analysis, allowing trends and risks to be identified across large datasets.

Turkington shared an example from an operating theatre where AI helped prevent cascading delays. When a surgical case ran late, a nurse verbally updated Orva that the patient was ready to exit. The system alerted the recovery unit, analyzed schedule conflicts, and prompted management to reassign staff before delays affected subsequent procedures.

Opinion

This section contains relevant reference points, placed in (Opinion field)

By tagging the cause of the delay and feeding that data into predictive models, the system helped prevent similar issues in the future — without additional manual coordination.

According to Seqqat, the primary returns from AI adoption come from combining efficiency with financial accuracy. Streamlined workflows allow providers to treat more patients without compromising care, while improved documentation reduces revenue leakage.

Looking ahead, Seqqat sees AI becoming central to Saudi Arabia’s healthcare transformation. He described its role as advancing smart hospitals, predictive patient flow, and precision medicine aligned with Vision 2030 goals.
“The role of AI in Saudi Arabia’s healthcare sector is evolving from a supporting technology to a foundational pillar of the Kingdom’s Vision 2030 transformation. Over the next few years, we expect to see AI move into the realm of smart hospitals, where predictive analytics optimize patient flow and AI-driven precision medicine leverages the Saudi Genome Program to provide hyper-personalized care. By unifying national health data and automating complex administrative workflows, AI will enable a more proactive, value-based healthcare model that improves patient outcomes and operational efficiency across the country.”